Premature pubarche in girls is associated with functional adrenal but not ovarian hyperandrogenism

Journal of Pediatrics

Volumn 141, Issue 1, 2002, Pages 91-98

  Mathew, Revi P ^a,b,c   Najjar, Jennifer L ^a,b,c   Lorenz, Rodney A ^a,b,c   Mayes, Darrel E ^a,b,c   Russell, William E ^a,b,c  

^a VANDERBILT UNIVERSITY   (United States)

^b UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^c Esoterix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; DEXAMETHASONE; ESTRADIOL; HYDROXYPROGESTERONE; LEUPRORELIN;

ADRENAL FUNCTION; ADRENAL SUPPRESSION; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG RESPONSE; FEMALE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; MENARCHE; PRECOCIOUS PUBERTY; PREPUBERTY; PRIORITY JOURNAL;

EID: 0036067399     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.125492     Document Type: Article

References (50)

1. Premature pubarche: Etiological heterogeneity
2. Premature adrenarche: A normal variant of puberty
3. The role of adrenocorticotropin testing in evaluating girls with premature adrenarche and hirsutism/oligomenorrhea
4. Normal and almost normal precocious variations in pubertal development: Premature pubarche and premature thelarche revisited
5. Natural history of premature pubarche: An auxological study
6. Premature adrenarche: Normal variant or forerunner of adult disease
7. Plasma 17-ketosteroids and 17-beta hydroxysteroids in girls with premature development of sexual hair
8. Adrenarche: Changing adrenal response to adrenocorticotropin
9. The development changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17, 20-desmolase
10. Detection of functional ovarian hyperandrogenism in women with androgen excess
11. Pituitary-ovarian response to nafarelin testing in the polcystic ovary syndrome
12. Potential of gonadotropin-releasing hormone agonists in the diagnosis of pubertal disorders in girls
13. Studies of the nature of 17 hydroxyprogesterone hyperresponsiveness to gonadotrophin releasing hormone agonist challenge in functional ovarian hyperandrogenism
14. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: Increased frequency of functional ovarian hyperandrogenism
15. Girls diagnosed with premature pubarche show an exaggerated ovarian androgen synthesis from the early stages of puberty: Evidence from gonadotrophin-releasing hormone agonist testing
16. Simultaneous radioimmunoassay of plasma FSH, LH, progesterone, 17-hydroxyprogesterone, and estradiol-17 beta during the menstrual cycle
17. Pulsatile patterns of gonadotropin release in subjects with and without ovarian function
18. Secondary sexual characteristics and menses in young girls seen in office practice: A study from the Pediatric Research in Office Settings network
19. Genotyping steroid 21-hydroxylase deficiency: Hormonal reference data
20. Acute hormonal response to the gonadotropin releasing hormone agonist leuprolide: Dose response studies and comparison to nafarelin: A clinical research center study
21. Normative data for adrenal steroidogenesis in healthy pediatric population: Age and sex related changes after adrenocorticotropin stimulation
22. Absence of non classical congenital adrenal hyperplasia in patients with precocious adrenarche
23. Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism
24. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism
25. Hyperinsulinemia, dyslipidemia and cardiovascular risk in girls with a history of premature pubarche
26. Precocious pubarche, dyslipidemia and low IGF binding protein-1 in girls: Relation to reduced prenatal growth
27. Hormonal findings in African-American and Caribbean Hispanic girls with premature adrenarche: Implications for polycystic ovary syndrome
28. Epidemiology of infertility and polycystic ovarian disease: Endocrinological and demographic studies
29. Genetic defects of steroidogenesis in premature pubarche
30. Absence of non classical congenital adrenal hyperplasia in patients with precocious adrenarche
31. Metabolic lessons from the study of young adults with polycystic ovary syndrome: Is insulin, indeed, the culprit?
32. Adrenal function in normal women and women with the polycystic ovarian syndrome
33. Plasma pregnenolone and 17 OH pregnenolone in patients with adrenal tumors, ACTH excess or idiopathic hirsutism
34. Absence of molecular defect in the type II 3 β hydroxysteroid dehydrogenase (3 β-HSD) gene in premature pubarche children and hirsute female patients with moderately decreased adrenal 3 beta HSD activity
35. Studies of 3 β hydroxysteroid dehydrogenase genes in infants and children manifesting premature pubarche and increased adrenocorticotropin-stimulated δ 5-steroid levels
36. Precocious puberty: Who has it? Who should be treated?
37. Reexamination of the age limit for defining when puberty is precocious in girls in the United States: Implications for evaluation and treatment
38. The polycystic ovary syndrome: Pathogenesis and treatment
39. Polycystic ovary syndrome as a form of functional hyperandrogenism due to dysregulation of androgen secretion
40. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response
41. Molecular biology of steroid hormone synthesis
42. Puberty: Ontogeny, neuroendocrinolgy, physiology, and disorder
43. Variation in the timing of puberty: Clinical spectrum and genetic investigation
44. Diagnosis of polycystic ovary syndrome
45. The role of pelvic ultrasound in the management of pediatric endocrine disorders
46. Diagnosis of the polycystic ovary syndrome in adolescence: Comparison of adolescent and adult hyperandrogenism
47. Pelvic ultrasonography in normal girls and in girls with pubertal precocity
48. The relationship between ovarian structure and hyperandrogenism in premature pubarche
49. Longitudinal changes of sonographic ovarian aspects and endocrine parameters in irregular cycles of adolescence